- Home
- CHR vs NERV Comparison
CHR vs NERV Comparison
Compare CHR & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHR
- NERV
- Stock Information
- Founded
- CHR 2016
- NERV 2007
- Country
- CHR China
- NERV United States
- Employees
- CHR N/A
- NERV N/A
- Industry
- CHR EDP Services
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- CHR Technology
- NERV Health Care
- Exchange
- CHR Nasdaq
- NERV Nasdaq
- Market Cap
- CHR 13.3M
- NERV 12.0M
- IPO Year
- CHR N/A
- NERV 2014
- Fundamental
- Price
- CHR $0.74
- NERV $2.18
- Analyst Decision
- CHR
- NERV Hold
- Analyst Count
- CHR 0
- NERV 1
- Target Price
- CHR N/A
- NERV $5.00
- AVG Volume (30 Days)
- CHR 757.3K
- NERV 43.7K
- Earning Date
- CHR 07-30-2025
- NERV 11-04-2025
- Dividend Yield
- CHR N/A
- NERV N/A
- EPS Growth
- CHR N/A
- NERV N/A
- EPS
- CHR 1.76
- NERV 1.48
- Revenue
- CHR $147,134,000.00
- NERV N/A
- Revenue This Year
- CHR N/A
- NERV N/A
- Revenue Next Year
- CHR N/A
- NERV N/A
- P/E Ratio
- CHR $0.41
- NERV $1.44
- Revenue Growth
- CHR N/A
- NERV N/A
- 52 Week Low
- CHR $0.65
- NERV $1.15
- 52 Week High
- CHR $3.45
- NERV $3.00
- Technical
- Relative Strength Index (RSI)
- CHR 28.80
- NERV 50.23
- Support Level
- CHR $0.71
- NERV $2.26
- Resistance Level
- CHR $1.06
- NERV $2.19
- Average True Range (ATR)
- CHR 0.11
- NERV 0.11
- MACD
- CHR -0.02
- NERV -0.04
- Stochastic Oscillator
- CHR 15.54
- NERV 21.05
About CHR Cheer Holding Inc.
Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerReal, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.